MENU
+Compare
CSCI
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$3.34
Change
-$0.03 (-0.89%)
Capitalization
10.4M

CSCI COSCIENS Biopharma Inc Forecast, Technical & Fundamental Analysis

Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries... Show more

Industry: #Biotechnology
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CSCI with price predictions
Jun 27, 2025

CSCI sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for CSCI moved above the 200-day moving average on June 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CSCI advanced for three days, in of 207 cases, the price rose further within the following month. The odds of a continued upward trend are .

CSCI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 41 cases where CSCI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on June 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CSCI as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CSCI turned negative on June 09, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

CSCI moved below its 50-day moving average on June 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CSCI crossed bearishly below the 50-day moving average on June 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.036) is normal, around the industry mean (16.377). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). CSCI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (1.075) is also within normal values, averaging (252.527).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CSCI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CSCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CSCI is expected to report earnings to rise 53.27% to -327 cents per share on August 08

COSCIENS Biopharma Inc CSCI Stock Earnings Reports
Q2'24
Est.
$-3.28
Q4'24
Beat
by $1.34
The last earnings report on April 09 showed earnings per share of -214 cents, beating the estimate of -348 cents. With 640.00 shares outstanding, the current market capitalization sits at 10.40M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TIPT24.722.23
+9.92%
Tiptree
VLCN6.850.13
+1.93%
Volcon Inc
ECBK15.270.19
+1.26%
ECB Bancorp
GNW7.840.03
+0.38%
Genworth Financial
CSL376.98N/A
N/A
Carlisle Companies

CSCI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CSCI has been closely correlated with NCNA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CSCI jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSCI
1D Price
Change %
CSCI100%
-0.89%
NCNA - CSCI
88%
Closely correlated
N/A
RNAC - CSCI
88%
Closely correlated
-6.81%
WINT - CSCI
87%
Closely correlated
+21.49%
BCDA - CSCI
81%
Closely correlated
-3.59%
NRXP - CSCI
79%
Closely correlated
-2.29%
More

Groups containing CSCI

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSCI
1D Price
Change %
CSCI100%
-0.89%
CSCI
(21 stocks)
4%
Poorly correlated
+0.32%